Form 4 for GILD Gilead Sciences
Accepted 2026-01-26 00:00:00 ET · period of report 2026-01-23 · accession 0001638643-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-26 | 2026-01-23 | GILD | O'Day Daniel Patrick | COB, CEO, Dir | M - OptEx | $66.01 | +115.6K | 682.3K | +20% | +$7.63M |
| D | 2026-01-26 | 2026-01-23 | GILD | O'Day Daniel Patrick | COB, CEO, Dir | S - Sale+OE | $135.00 | -115.6K | 566.7K | -17% | -$15.61M |
| D | 2026-01-26 | 2026-01-23 | GILD | O'Day Daniel Patrick | COB, CEO, Dir | M - OptEx | $0.00 | -115.6K | 115.6K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-23 | M | A | 115,640 | $66.01 | 682,338 | D | — | — | |
| 2 | Common | Common Stock | 2026-01-23 | S | D | 115,640 | $135.00 | 566,698 | D | — | — | |
| 3 | Derivative | Non-qualified Stock Option (Right to Buy) | 2026-01-23 | M | D | 115,640 | $0.00 | 115,640 | D | $66.01 · — to 2029-03-01 | 115,640 Common Stock | (F2) The stock options have a four-year vesting schedule. 25% of the stock options vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. |